- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
Clinical Trial Updates at the ADA Scientific Sessions 2021: A few primary care musts
The American Diabetes Association 2021 Scientific Sessions run from June 25 to 29. This short slide show highlights 6 clinical trial updates that are a "must see" for primary care clinicians.
The American Diabetes Association Virtual 81st Scientific Sessions kick off on Friday, June 25 and run through Tuesday, June 29, 2021.
The topics to be covered this year include many focused on the impact of COVID-19 on persons with diabetes and on their care. There are hundreds of poster presentations and updates on both ongoing and published clinical trial programs studying drug classes that might once have targeted only hyperglycemia but now are proving effective in cardiovascular and renal disease.
The following slides provide a brief look at 6 clinical trial updates our editors think will be of particular interest to clinicians in primary care. (Note: All times are EST)
